These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 18030510

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Cost of colorectal cancer in France in 1999].
    Selke B, Durand I, Marissal JP, Chevalier D, Lebrun T.
    Gastroenterol Clin Biol; 2003 Jan; 27(1):22-7. PubMed ID: 12594362
    [Abstract] [Full Text] [Related]

  • 3. Cost of diagnostic and therapeutic management of colorectal cancer according to stage at diagnosis in the Calvados Département, France.
    Bouvier V, Reaud JM, Gignoux M, Launoy G.
    Eur J Health Econ; 2003 Jan; 4(2):102-6. PubMed ID: 15609176
    [Abstract] [Full Text] [Related]

  • 4. Cost of pretherapeutic staging of patients with colorectal cancer metastases in a French population.
    Lejeune C, Logé P, Arveux P, Velten M, Jolly D, Woronoff-Lemsi MC, Guillemin F.
    Clin Res Hepatol Gastroenterol; 2011 May; 35(5):399-407. PubMed ID: 21317060
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland.
    Delcò F, Egger R, Bauerfeind P, Beglinger C.
    Aliment Pharmacol Ther; 2005 Mar 01; 21(5):615-22. PubMed ID: 15740546
    [Abstract] [Full Text] [Related]

  • 9. [Cost-effectiveness evaluation of predictive molecular diagnostics using the example of hereditary non-polyposis colorectal cancer (HNPCC)].
    Hagen A, Hessabi HK, Gorenoi V, Schönermark MP.
    Gesundheitswesen; 2008 Jan 01; 70(1):18-27. PubMed ID: 18273760
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Colonoscopy surveillance in asymptomatic subjects with increased risk for colorectal cancer: clinical evaluation and cost analysis of an Italian experience.
    Matarese VG, Feo CV, Pezzoli A, Trevisani L, Brancaleoni M, Gullini S.
    Eur J Cancer Prev; 2007 Aug 01; 16(4):292-7. PubMed ID: 17554201
    [Abstract] [Full Text] [Related]

  • 12. Lifetime costs of colon and rectal cancer management in Canada.
    Maroun J, Ng E, Berthelot JM, Le Petit C, Dahrouge S, Flanagan WM, Walker H, Evans WK.
    Chronic Dis Can; 2003 Aug 01; 24(4):91-101. PubMed ID: 14733758
    [Abstract] [Full Text] [Related]

  • 13. Trends in frequency and management of obstructing colorectal cancers in a well-defined population.
    Cheynel N, Cortet M, Lepage C, Benoit L, Faivre J, Bouvier AM.
    Dis Colon Rectum; 2007 Oct 01; 50(10):1568-75. PubMed ID: 17687610
    [Abstract] [Full Text] [Related]

  • 14. [Surgical health care patterns and cancer cost: two studies using population registry data].
    Schraub S, Arveux P, Mercier M, Gauthier M.
    Rev Epidemiol Sante Publique; 1996 Oct 01; 44 Suppl 1():S33-9. PubMed ID: 8935862
    [Abstract] [Full Text] [Related]

  • 15. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
    Ramsey SD, Berry K, Etzioni R.
    Am J Gastroenterol; 2002 Feb 01; 97(2):440-5. PubMed ID: 11866285
    [Abstract] [Full Text] [Related]

  • 16. Cost of care for elderly cancer patients in the United States.
    Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, Brown ML.
    J Natl Cancer Inst; 2008 May 07; 100(9):630-41. PubMed ID: 18445825
    [Abstract] [Full Text] [Related]

  • 17. [Economic aspects of oncologic surgery: what do we know, are they relevant; must--may--we regard them?].
    Nagel E, Meyer zu Vilsendorf A, Obermann K.
    Langenbecks Arch Chir Suppl Kongressbd; 1996 May 07; 113():91-7. PubMed ID: 9102021
    [Abstract] [Full Text] [Related]

  • 18. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F, Günther KP, Witzlebf WC.
    Eur J Med Res; 2008 Jun 24; 13(6):267-74. PubMed ID: 18558552
    [Abstract] [Full Text] [Related]

  • 19. The economic impact of false-positive cancer screens.
    Lafata JE, Simpkins J, Lamerato L, Poisson L, Divine G, Johnson CC.
    Cancer Epidemiol Biomarkers Prev; 2004 Dec 24; 13(12):2126-32. PubMed ID: 15598770
    [Abstract] [Full Text] [Related]

  • 20. Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.
    Fourcade RO, Benedict A, Black LK, Stokes ME, Alcaraz A, Castro R.
    BJU Int; 2010 Jan 24; 105(1):49-56. PubMed ID: 20132102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.